BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2379016)

  • 1. Pseudoporphyria due to dyazide in a patient with vitiligo.
    Motley RJ
    BMJ; 1990 Jun; 300(6737):1468. PubMed ID: 2379016
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic diabetes insipidus associated with Dyazide (triamterene-hydrochlorothiazide).
    Macleod MD; Bell GM; Irvine WJ
    Br Med J (Clin Res Ed); 1981 Oct; 283(6300):1155-6. PubMed ID: 6794799
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of kidney stones.
    Ettinger B
    JAMA; 1982 Oct; 248(16):1971. PubMed ID: 7120618
    [No Abstract]   [Full Text] [Related]  

  • 4. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 5. Amantadine-dyazide interaction.
    Wilson TW; Rajput AH
    Can Med Assoc J; 1983 Nov; 129(9):974-5. PubMed ID: 6671185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 7. Lithium intoxication and its clinical management.
    Demers RG; Rivenbark JF
    South Med J; 1982 Jun; 75(6):738-9. PubMed ID: 6965275
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Dyazide and hyperkalemia.
    Petersen AG
    Ann Intern Med; 1976 May; 84(5):612-3. PubMed ID: 1275375
    [No Abstract]   [Full Text] [Related]  

  • 9. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
    Blume CD; Williams RL
    Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatraemia induced by a combination of hydrochlorothiazide and triamterene.
    Roberts CJ; Channer KS; Bungay D
    Br Med J (Clin Res Ed); 1984 Jun; 288(6435):1962. PubMed ID: 6428623
    [No Abstract]   [Full Text] [Related]  

  • 11. Triamterene nephrolithiasis complicating dyazide therapy.
    Patel KM
    J Urol; 1981 Aug; 126(2):230. PubMed ID: 7265370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide.
    Blume CD; Williams RL; Upton RA; Lin ET; Benet LZ
    Am J Med; 1984 Nov; 77(5A):59-61. PubMed ID: 6496560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
    Hollenberg NK; Mickiewicz CW
    Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrochlorothiazide-associated pulmonary edema.
    Anderson TJ; Berthiaume Y; Matheson D; Boiteau P
    Chest; 1989 Sep; 96(3):695-7. PubMed ID: 2766837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol ... not guilty.
    Packard RC
    Headache; 1987 Nov; 27(10):587. PubMed ID: 3692823
    [No Abstract]   [Full Text] [Related]  

  • 16. Triamterene crystalline nephropathy.
    Nasr SH; Milliner DS; Wooldridge TD; Sethi S
    Am J Kidney Dis; 2014 Jan; 63(1):148-52. PubMed ID: 23958399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene.
    Darken M; McBurney EI
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):38-42. PubMed ID: 3346407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case study: drug-induced electrolyte changes.
    Weishar C
    Am J Med Technol; 1982 May; 48(5):339-41. PubMed ID: 7102716
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination.
    Hansen KB; Bender AD
    Clin Pharmacol Ther; 1967; 8(3):392-9. PubMed ID: 6026787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.